Certain A Shares of Medprin Regenerative Medical Technologies Co., Ltd. are subject to a Lock-Up Agreement Ending on 26-JUL-2023. These A Shares will be under lockup for 741 days starting from 15-JUL-2021 to 26-JUL-2023.

Details:
The Company?s holding shareholder and actual controller Yuan Yuyu, person acting in concert Xu Tao, and Yuan Yuyu?s controlled ESOP?s Guangzhou Napusheng Investment Partnership Enterprise (Limited Partnership) and Guangzhou Natong Investment Partnership Enterprise (Limited Partnership) promised to not transfer or entrust to a third party the Company?s shares they hold directly or indirectly before the issuance, or allow the company to repurchase those shares within 36 months from the listing date. If within 6 months after the listing, the closing price of the shares is lower than the issuance price for 20 consecutive trading days or if the trading price is lower than the issuance price 6 months after listing, the lock-up period will be automatically extended for another 6 months. After the lock-up has expired, while holding office, Yuan Yuyu committed to not transfer more than 25% of shares held each year. The Company?s other directors, supervisors, and senior management promised to not transfer or entrust to a third party the Company?s shares they hold directly or indirectly before the issuance, or allow the company to repurchase those shares within 36 months from the listing date. If within 6 months after the listing, the closing price of the shares is lower than the issuance price for 20 consecutive trading days or if the trading price is lower than the issuance price 6 months after listing, the lock-up period will be automatically extended for another 6 months. After the lock-up has expired, while holding office, they committed to not transfer more than 25% of shares held each year.

The Company?s shareholder Yuan Meifu promised to not transfer or entrust to a third party the Company?s shares they hold directly or indirectly before the issuance, or allow the company to repurchase those shares within 12 months from the listing date. If within 6 months after the listing, the closing price of the shares is lower than the issuance price for 20 consecutive trading days or if the trading price is lower than the issuance price 6 months after listing, the lock-up period will be automatically extended for another 6 months. After the lock-up has expired, while holding office, Yuan Meifu committed to not transfer more than 25% of shares held each year. The Company?s shareholders Shenzhen Kaiying Technology Co., Ltd., Tang Ying, Guoshou Chengda (Shanghai) Health Industry Equity Investment Center (Limited Partnership), Guangzhou Lingkang Investment Partnership Enterprise (Limited Partnership), Cai Wanting, Suzhou Fenxiang Hi-Tech Medical Treatment Industry Venture Capital Enterprise (Limited Partnership), Gongqingcheng Fenxiang Houde Guoqian Innovation Investment Management Partnership Enterprise (Limited Partnership), Guangzhou Huangpu Feijun Industry Investment Fund Partnership Enterprise (Limited Partnership), Guangzhou Yueke Intellectual Property Operations Investment Center (Limited Partnership), Anhui Huizhifu Venture Capital Co., Ltd., Guangzhou Huangpu Yongping Kechuang Equity Investment Partnership Enterprise (Limited Partnership), Tan Pengcheng promised to not transfer or entrust to a third party the Company?s shares they hold directly or indirectly before the issuance, or allow the company to repurchase those shares within 12 months from the listing date.